Gleacher & Co Initiates Coverage on Biotechnology/Drug Manufacturers Stocks (IDIX, VRUS, & VRTX)
Tweet Send to a FriendGet Alerts IDIX Hot Sheet
Price: $4.31 +2.86%
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade IDIX Now!
Gleacher & Co initiates coverage on Idenix Pharmaceuticals (Nasdaq: IDIX) (PT $7) and Pharmasset, Inc. (Nasdaq: VRUS) (PT $45) with Buy ratings.
Gleacher & Co initiates coverage on Vertex Pharmaceuticals (Nasdaq: VRTX) with a Neutral rating. PT $41.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Gleacher & Co initiates coverage on Vertex Pharmaceuticals (Nasdaq: VRTX) with a Neutral rating. PT $41.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Deutsche Bank Starts Kodiak Oil & Gas (KOG) at Hold
- Roth Capital Resumes Crown Crafts (CRWS) at Buy
- UPDATE: MKM Partners Downgrades Alkermes (ALKS) to Sell
Create E-mail Alert Related Categories
New Coverage
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
